Bryan King is professor of psychiatry and vice chair of child and adolescent psychiatry at the University of California, San Francisco.
Bryan King
Vice chair of psychiatry and behavioral sciences, University of Washington
From this contributor
Combination of strategies may tame autism’s placebo problem
Clinical trials of autism treatments are fertile ground for the placebo effect. Bryan King explains how the field must move forward to better evaluate treatments.
Combination of strategies may tame autism’s placebo problem
Explore more from The Transmitter
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.